Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT03571451Unknown

A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform

Role: collaborator

NCT04948424Completed

A Retrospective Observational Study to Describe Anaemia Management, Burden of Disease and Outcomes in Chinese Patients on Peritoneal Dialysis Using a Clinical Database

Role: collaborator

NCT05619861Not ApplicableUnknown

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Role: collaborator

NCT04958447Unknown

Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China

Role: collaborator

NCT03947411Not ApplicableUnknown

Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms

Role: collaborator

NCT03916432Not ApplicableUnknown

HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population

Role: collaborator

NCT03417063Unknown

Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression

Role: collaborator

NCT02552342Phase 4Unknown

Corticosteroid Therapy for Severe Community-Acquired Pneumonia

Role: collaborator

All 8 trials loaded